These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1874374)

  • 1. [Myelopid correction of disorders in marker characteristics of surface membrane and cytoplasm of neutrophil granulocytes in children with pyoseptic diseases].
    Nesterova IV; Tarakanov VA; Luniaka AN
    Gematol Transfuziol; 1991 May; 36(5):31-4. PubMed ID: 1874374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of the action of myelopid and taktivin on bone marrow].
    Bazarnyĭ VV; Osipenko AV
    Biull Eksp Biol Med; 1993 Mar; 115(3):273-4. PubMed ID: 8054620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of myelopid on antibody formation in gamma-irradiated animals].
    Vartanova AI; Stepanenko RN
    Radiobiologiia; 1991; 31(3):387-90. PubMed ID: 1887007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of myelopid on the ultrastructural changes in the rat myocardium induced by an endotoxin].
    Kharlanova NG; Lomov IuM; Bardakhch'ian EA
    Fiziol Zh (1994); 1996; 42(1-2):25-30. PubMed ID: 8991710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective, immunocorrective and stimulant effects of myelopeptides on intact and damaged system of neutrophil granulocytes in an experiment].
    Nesterova IV; Tarakanov VA; Luniaka AN
    Gematol Transfuziol; 1992; 37(5-6):37-9. PubMed ID: 1478433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemiluminescent analysis of the functional state of cellular and humoral components of neutrophil phagocytosis system in recurrent herpes simplex].
    Rezaĭkina AV; Kurshakova TS; Kolieva M; Fedorov SM
    Klin Lab Diagn; 1995; (1):21-3. PubMed ID: 7757360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation by myelopid of immunoglobulin production in culture of human peripheral blood lymphocytes in normal and secondary immunodeficient state].
    Vlasenko RIa; Stepanenko RN; Koval'chuk LV
    Biull Eksp Biol Med; 1990 Aug; 110(8):180-2. PubMed ID: 2291967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulating therapy with myelopid in experimental Salmonella infection].
    Osmanova LIa; Gurariĭ NI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):94-7. PubMed ID: 2686306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunomorphology and immune correction during experimental calf enterobacteriosis].
    Zharov AV
    Biull Eksp Biol Med; 1999 Mar; 127(3):321-3. PubMed ID: 10225111
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of neuroendocrine disorders in traumatic toxicosis using mielopid].
    Samsonenko RA; El'skiĭ VN; Evtushenko SK; Titievskiĭ AV
    Patol Fiziol Eksp Ter; 1990; (2):28-30. PubMed ID: 2166271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients].
    Lisianyĭ NI; Romodanov SA; Radzievskiĭ AA; Rudenko VA; Pedachenko EG
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (3):16-8. PubMed ID: 1661534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of myelopid in immunodeficiency states].
    Petrov RV; Borisova AM; Glazko AV; Simonova AV; Stepanenko RN
    Ter Arkh; 1990; 62(12):81-7. PubMed ID: 2084931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of immunoactive substances on sensitivity of the retina to light].
    Abramov VV; Bezgachev VG; Gromykhina NIu; Batoeva ATs; Kozhevnikov VS
    Dokl Akad Nauk SSSR; 1988; 303(1):249-51. PubMed ID: 3266141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
    Cheknev SB; Latysheva OL; Denisov LA; Ershov FI
    Biull Eksp Biol Med; 1992 Feb; 113(2):179-82. PubMed ID: 1377045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The neurotropic effect of myelopide on rat motor activity--stereotypical movement, locomotion, and grooming].
    Lepekhina LM; Bibkova LA
    Biull Eksp Biol Med; 1994 Oct; 118(10):414-6. PubMed ID: 7865823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stimulating effect of myelopid on the regeneration of the medullary hematopoiesis in experimental acute radiation sickness].
    Deshevoĭ IuB; Moroz BB; Lebed' VG; Stepanenko RN
    Radiats Biol Radioecol; 1994; 34(4-5):561-4. PubMed ID: 7951884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of changes in blood immune indicators after intralymphatic administration of gentamycin and myelopid in combined prevention of complications in ulcerative colitis and Crohn disease].
    Domoratskiĭ IE
    Klin Khir (1962); 1994; (4):46-8. PubMed ID: 7799589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor necrosis factor and possibilities of correction of its production in patients with suppurative-septic complications in terminal states].
    Leshin AA; Pisarev VM; Kremlev SG; Tutel'ian AV; Lebedev VV
    Anesteziol Reanimatol; 1993; (2):38-40. PubMed ID: 7943878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
    McPherson SJ; Thomas TZ; Wang H; Gurusinghe CJ; Risbridger GP
    J Endocrinol; 1997 Sep; 154(3):535-45. PubMed ID: 9379131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.